News

Osteoboost Wins Big at the 2024 Hitlab Women’s Health Tech Event

Last week I had the honor of presenting Osteoboost, our soon-to-launch FDA-cleared precision vibration therapy medical device, at the 2024 Hitlab Women’s Health Tech event held on October 11. And I’m thrilled to report that Osteoboost won both first place in the seed-stage category and the event’s People’s Choice Award!…
Read more

Two women walking wearing Osteoboost belts overlaid by two smartphones showing the Wellen exercise app

Bone Health Technologies Acquires Wellen

Bone Health Technologies takes a pivotal step toward a future of comprehensive one-stop bone health care for patients everywhere REDWOOD CITY, Calif. (July 25, 2024) – Bone Health Technologies (BHT), a leading medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health and reduce fractures, today announced the company…
Read more

Bone Health Technologies Granted Fifth U.S. Patent for Low Bone Density Treatment Osteoboost, Adds Two Key Executives

REDWOOD CITY, CA (July 2, 2024) – Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, today announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia. The patent, US…
Read more

Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care

BHT closes oversubscribed financing round, adds new investors to revolutionize low bone density treatments Redwood City, CA – March 4, 2024 – Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round from…
Read more

Osteoboost in the News

Catch up on the latest news coverage of Bone Health Technologies and the breakthrough Osteoboost belt for osteopenia treatment.

Bone Health Technologies Announces FDA Clearance of Osteoboost, the First Prescription Medical Device to Treat Low Bone Density

Redwood City, CA – January 18, 2024 – Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia (low bone density).  Osteoboost is a wearable belt device, worn on the…
Read more

Bone Health Technologies Awarded New Patent for Wearable Treatment for Osteopenia and Osteoporosis in Post-Menopausal Women 

First Device to Demonstrate Bone Strength Benefit in Clinical Trial REDWOOD CITY, CA (DEC, 2023)– Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, has been granted its fourth patent to further its commercialization of the Osteoboost device. Osteoboost has been shown in clinical trials…
Read more